# OnCo record twostep-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/twostep-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "twostep-therapeutics" ;
  schema:name "TwoStep Therapeutics"@en ;
  schema:description "TwoStep Therapeutics makes small peptides that home in on proteins found on many solid tumours and carry a cancer drug to them. Its first medicine, TS-104, started an early trial in 2026."@en ;
  schema:url <https://onco.cc/companies/twostep-therapeutics/>, <https://twosteptx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://twosteptx.com/>, <https://twosteptx.com/twostep-therapeutics-announces-oversubscribed-62-5-million-series-a-financing-and-fda-clearance-of-ind-for-first-in-class-peptide-drug-conjugate/>, <https://clinicaltrials.gov/study/NCT07814248> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/esophageal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> .